Kymera Therapeutics Vs. Aritzia Industry Stock Comparison

Buy

75

KYMR
Kymera Therapeutics

Last Price:

48.67

Seasonality Move:

52.76%

Sell

40

ATZAF
Aritzia

Last Price:

33.13

Seasonality Move:

14.48%

Buy

75

Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

The current Kymera Therapeutics [KYMR] share price is $50.05. The Score for KYMR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

40

Aritzia (ATZAF) is a Sell

Is Aritzia a Buy, Sell or Hold?

The current Aritzia [ATZAF] share price is $32.80. The Score for ATZAF is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
ATZAF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

The Kymera Therapeutics share price today is $50.05
The current trend is moderately bullish and KYMR is experiencing slight selling pressure.

ATZAF Stock Price Chart

What is Aritzia's stock price today?

The Aritzia share price today is $32.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATZAF is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	1.03	Buy
Relative Strength Index (14 RSI):	57.39	Buy
Chaikin Money Flow:	-137989	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(45.13 - 49.75)	Buy
Bollinger Bands (100):	(38.59 - 49.75)	Buy

ATZAF Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.9	Sell
Relative Strength Index (14 RSI):	50.73	Buy
Chaikin Money Flow:	7616	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(30.43 - 34.95)	Buy
Bollinger Bands (100):	(30.1 - 35.52)	Sell

KYMR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	49.18	Buy
20-day SMA:	48.27	Buy
50-day SMA:	47.21	Buy
200-day SMA:	40.45	Buy
8-day EMA:	49.65	Buy
20-day EMA:	48.44	Buy
50-day EMA:	46.96	Buy
200-day EMA:	40.14	Buy

ATZAF Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	31.79	Buy
20-day SMA:	31.82	Buy
50-day SMA:	34.06	Sell
200-day SMA:	29.5	Buy
8-day EMA:	31.34	Buy
20-day EMA:	32.22	Buy
50-day EMA:	33.01	Sell
200-day EMA:	29.97	Buy

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.50 per share.

Aritzia Earnings Growth & ATZAF Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.68 per share, and an increase next year of $0.57 per share.

Kymera Therapeutics Technical Analysis

	Oct 30	Oct 31	Nov 1	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12
	Oct			Nov
	30	31	01	04	05	06	07	08	11	12
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aritzia Technical Analysis

	Oct 30	Oct 31	Nov 1	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12
	Oct			Nov
	30	31	01	04	05	06	07	08	11	12
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):